Page 17 - Mesenchymal Stem cells, Exosomes and vitamins in the fight aginst COVID

Pain Physician: March/April 2020: 23:E71-E83

PressAnnouncements/ucm573427.htm. www .fda.gov /ICECI / 97. Liang B, Chen J, Li T, et al. Clinical
81. Regulatory Considerations for Human EnforcementActions/WarningLetters/ remission of a critically ill COVID-19
Cell, Tissues, and Cellular and Tissue- ucm591225.htm. patient treated by human umbilical cord
Based Products: Minimal Manipulation 89. Associated Press. North Darkota stem mesenchymal stem cells. ChinaXiv 2020;
and Homologous Use. Guidance cell clinic investigated after complaints. 202002.00084.
for Industry and Food and Drug The Seattle Times, November 16, 2017. 98. China uses stem cell therapy to treat
Administration Staff, November 2017. Accessed date 3/18/2020. severe coronavirus cases. Gulf News,
Accessed date 3/18/2020. www.seattletimes.com/nation- March 5, 2020. Accessed date: 3/15/2020.
www .fda.gov /downloads/ world/bismarck-stem-cell-clinic- https://gulfnews.com/world/asia/china-
B i o l o g i c s B l o o d V a c c i n e s / investigated-after-complaints/ uses-stem-cell-therapy-to-treat-severe-
GuidanceCompliance - 90. Kuriyan AE, Albini TA, Townsend JH, coronavirus-cases-1.1583399782425
RegulatoryInformation/Guidances/ et al. Vision loss after intravitreal 99. ClinicalTrials.gov. Mesenchymal
CellularandGeneTherapy/UCM585403. injection of autologous “stem cells” Stem Cell Treatment for Pneumonia
pdf for AMD. N Engl J Med 2017; 376:1047- Patients Infected With 2019 Novel
82. U.S. Department of Health and Human 1053. Coronavirus. ClinicalTrials.gov Identifier:
Services. Same Surgical Procedure 91. Malarkey MA. Warning letter to David NCT04252118. Accessed date 3/15/2020.
Exception under 21 CFR 1271.15(b): G. Eller, Chief Executive Officer https://clinicaltrials.gov/ct2/show/
Questions and Answers Regarding the and President, Celltex Therapeutics NCT04252118
Scope of the Exception. Guidance for Corporation. Rockville, MD: Public 100. ClinicalTrials.gov. Umbilical Cord
Industry. November 2017. Health Service, Food and Drug (UC)-Derived Mesenchymal Stem
www .fda.gov /downloads/ Administration; September 24, 2012. Cells (MSCs) Treatment for the
BiologicsBlood-VaccinesdanceComplia Accessed date 3/18/2020. 2019-novel Coronavirus (nCOV)
nceRegulatoryInformation/Guidances/ www .fda.gov /ICECI / Pneumonia. ClinicalTrials.gov Identifier:
Tissue/UCM419926.pdf Accessed date E n f o r c e me nt A c t i o n s / NCT04269525. Accessed date 3/15/2020.
3/18/2020. WarningLetters/2012/ucm323853.htm https://clinicaltrials.gov/ct2/show/NCT0
83. U.S. Food and Drug Administration. 92. Schwarz A. New procedure uses 4269525?term=stem+cells&cond=Coron
Regenerative medicine advanced athletes’ own blood to treat injuries. a+Virus+Infection&draw=2
therapy designation. March 13, 2017. New York Times, 2009, A1. Accessed 101. ClinicalTrials.gov. Study of Human
Accessed date 3/18/2020. date 3/18/2020. Umbilical Cord Mesenchymal Stem Cells
www.fda.gov/BiologicsBloodVaccines/ www.nytimes.com/2009/ 02/17/ in the Treatment of Novel Coronavirus
CellularGeneTherapyProducts/ sports/17blood.html. Severe Pneumonia. ClinicalTrials.gov
ucm537670.htm 93. Piuzzi N, Ng M, Chughtai M, et al. Identifier: NCT04273646. Accessed date
84. Murray IR, Chahla J, Frank RM, Piuzzi The stem-cell market for the treatment 3/15/2020.
NS, Mandelbaum BR, Dragoo JL; of knee osteoarthritis: A patient https://clinicaltrials.gov/ct2/show/NCT0
Members of the Biologics Association. perspective. J Knee Surg 2018; 31:551- 4273646?term=stem+cells&cond=Coron
Rogue stem cell clinics. Bone Joint J 556. a+Virus+Infection&draw=2
2020; 102-B:148-154. 94. Turner L, Knoepfler P. Selling stem 102. ClinicalTrials.gov. Therapy for
85. Aicher RH. Is the FDA regulating the cells in the USA: Assessing the direct- Pneumonia Patients Infected by 2019
practice of medicine? Aesthet Surg J 2013; to-consumer industry. Cell Stem Cell Novel Coronavirus. ClinicalTrials.gov
33:452-455. 2016; 19:154-157. Identifier: NCT04293692. Accessed date
86. Charo A, Sipp D. Rejuvenating 95. Government of Canada. Health 3/15/2020.
regenerative medicine regulation. N Canada Policy Position Paper – https://clinicaltrials.gov/ct2/show/NCT0
Engl J Med 2018; 378:504-505. Autologous Cell Therapy Products. 4293692?term=stem+cells&cond=Coron
87. Malarkey MA. Warning letter to Thomas Accessed date 3/18/2020. a+Virus+Infection&draw=2&rank=7
E. Young, MD, Owner and Medical www.canada.ca/en/health-canada/ 103. Alcayaga-Miranda F, Cuenca J,
Director, Young Medical Spa. Rockville, services/drugs-health-products/ Khoury M. Antimicrobial activity of
MD: Public Health Service, Food and biologics-radiopharmaceuticals- mesenchymal stem cells: Current status
Drug Administration; April 20, 2012. genetic-therapies/applications- and new perspectives of antimicrobial
Accessed date 3/18/2020. submissions/guidance-documents/ peptide-based therapies. Front Immunol
www .fda.gov /ICECI / cell-therapy-policy.html 2017; 8:339.
E n f o r c e m e n t A c t i o n s / 96. Chen S. Coronavirus: critically ill 104. Predictive Technology Group Addresses
WarningLetters/2012/ucm301620.htm Chinese patient saved by stem cell Use of Mesenchymal Stem Cells in
88. Warning Letter to John S. Arnone, therapy, study says. South China Treatment of Secondary Issues Related
American CryoStem Corporation from Morning Post, March 2, 2020. Accessed to Coronavirus. GlobeNewswire, March
Elizabeth Waltrip, Acting Program date 3/18/2020. 17, 2020.
Division Director, Office of Biological www.scmp.com/news/china/society/ https://finance.yahoo.com/news/
Products Operations – Division 1, article/3053080/coronavirus-critically- predictive-technology-group-addresses-
U.S. Food and Drug Administration. ill-chinese-patient-saved-stem-cell mesenchymal-154552966.html
Accessed date 3/18/2020

E82 www.painphysicianjournal.com